Western pharma firms paid Russian distributors linked to fraud, report alleges

A whistleblower report alleges Merck, Eli Lilly, Novartis, and AstraZeneca made payments to Russian distributors involved in a corruption scheme that inflated drug prices and stifled competition in Russia's public healthcare system. The claims are unverified and the companies have not yet responded. If substantiated, this could expose Western firms to legal and reputational risk and complicate their operations in Russia.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works